| Primary |
| Lumbar Pain |
66.7% |
| Ovulation Induction |
33.3% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
25.9% |
| Product Used For Unknown Indication |
10.5% |
| Pain |
8.5% |
| Hypertension |
7.2% |
| Suicide Attempt |
5.2% |
| Unevaluable Event |
5.2% |
| Depression |
5.0% |
| Rheumatoid Arthritis |
3.6% |
| Ill-defined Disorder |
3.3% |
| Sciatica |
3.3% |
| Back Pain |
2.8% |
| Multiple Myeloma |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Abdominal Pain |
2.2% |
| Essential Hypertension |
2.2% |
| Polyarthritis |
2.2% |
| Urinary Tract Infection |
2.2% |
| Abscess |
1.9% |
| Post-traumatic Pain |
1.7% |
| Procedural Pain |
1.7% |
|
| Renal Failure |
19.4% |
| Jaundice |
9.0% |
| Somnolence |
9.0% |
| Cytolytic Hepatitis |
6.0% |
| Vomiting |
6.0% |
| Febrile Neutropenia |
4.5% |
| Hyperammonaemia |
4.5% |
| Lung Disorder |
4.5% |
| Visual Acuity Reduced |
4.5% |
| Acute Generalised Exanthematous Pustulosis |
3.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.0% |
| Fall |
3.0% |
| Gamma-glutamyltransferase Increased |
3.0% |
| Generalised Oedema |
3.0% |
| Hepatitis Cholestatic |
3.0% |
| Hypotension |
3.0% |
| Memory Impairment |
3.0% |
| Neutropenia |
3.0% |
| Pancreatitis |
3.0% |
| Pancreatitis Acute |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
43.6% |
| Rheumatoid Arthritis |
13.4% |
| Hypertension |
8.3% |
| Pain |
4.2% |
| Multiple Myeloma |
2.9% |
| Gastric Cancer |
2.5% |
| Diabetes Mellitus |
2.3% |
| Depression |
2.2% |
| Osteoporosis |
2.2% |
| Ankylosing Spondylitis |
2.1% |
| Prophylaxis |
2.1% |
| Torticollis |
2.1% |
| Anxiety |
1.9% |
| Hypersensitivity |
1.9% |
| Hypercholesterolaemia |
1.6% |
| Thrombosis Prophylaxis |
1.5% |
| Back Pain |
1.4% |
| Colorectal Cancer Metastatic |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Insomnia |
1.2% |
|
| Pyrexia |
10.6% |
| Renal Failure Acute |
8.3% |
| Vomiting |
8.3% |
| Toxic Skin Eruption |
6.8% |
| Renal Failure |
6.1% |
| Septic Shock |
5.3% |
| Creutzfeldt-jakob Disease |
4.5% |
| Personality Change |
4.5% |
| Pulmonary Embolism |
4.5% |
| Pyomyositis |
4.5% |
| Thrombocytopenia |
4.5% |
| Vertigo |
4.5% |
| Gamma-glutamyltransferase Increased |
3.8% |
| Retinal Vein Thrombosis |
3.8% |
| Transient Ischaemic Attack |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Diplopia |
3.0% |
| Drug Exposure During Pregnancy |
3.0% |
| General Physical Health Deterioration |
3.0% |
| Myalgia |
3.0% |
|
| Interacting |
| Pain |
21.8% |
| Drug Use For Unknown Indication |
20.0% |
| Epilepsy |
10.9% |
| Bone Pain |
7.3% |
| Hypertension |
7.3% |
| Constipation |
3.6% |
| Hypercholesterolaemia |
3.6% |
| Infection |
3.6% |
| Major Depression |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Agitation |
1.8% |
| Arrhythmia |
1.8% |
| Chest Injury |
1.8% |
| Depression |
1.8% |
| Facial Neuralgia |
1.8% |
| Psychotic Disorder |
1.8% |
| Sciatica |
1.8% |
| Urinary Incontinence |
1.8% |
|
| International Normalised Ratio Increased |
18.8% |
| Fall |
12.5% |
| Malaise |
12.5% |
| Morbid Thoughts |
6.3% |
| Nystagmus |
6.3% |
| Overdose |
6.3% |
| Road Traffic Accident |
6.3% |
| Somnolence |
6.3% |
| Thirst |
6.3% |
| Urinary Tract Infection |
6.3% |
| Visual Impairment |
6.3% |
| Vomiting |
6.3% |
|
